AP

Amruta Padmakar Bauskar

Active Director Director DIN 10590572
DIN 10590572 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Amruta Padmakar Bauskar

Data last updated:

Amruta Padmakar Bauskar is a Director at Bioprospera Clinical Research Private Limited (since 2024). The company operates in Pharma.

DIN 10590572
Primary Designation Director
Industry Pharma
First Appointment 13 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Apr 20242024Active

Board colleagues of Amruta Padmakar Bauskar

Directorship timeline

Open interactive timeline →
Bioprospera Clinical Research Private Limited
Premium access

Shareholding and investment profile for Amruta Padmakar Bauskar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amruta Padmakar Bauskar

Amruta Padmakar Bauskar currently holds 1 directorship: Bioprospera Clinical Research Private Limited (Director, since 13 Apr 2024).

Amruta Padmakar Bauskar was first appointed on 13 Apr 2024 as Director at Bioprospera Clinical Research Private Limited.

The current boards of Amruta Padmakar Bauskar's companies include Ravindra Devidas Mote (Bioprospera Clinical Research Private Limited), Vandana Shailesh Singh (Bioprospera Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available